Inspire Veterinary Partners Announces Closing of $6 Million Public Offering
Inspire Veterinary Partners Announces Closing of $6 Million Public Offering
VIRGINIA BEACH, VA / ACCESSWIRE / July 10, 2024 / Inspire Veterinary Partners, Inc. (Nasdaq:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced the closing of its previously announced public offering of 6,000,000 units, each unit consisting of either one share of the Company's Class A common stock or one pre-funded warrant to purchase one share of the Company's Class A common stock and one warrant to purchase one share of the Company's Class A common stock at a public offering price of $1.00 per unit.The pre-funded warrants are issuable to purchasers in lieu of shares of Class A common stock that would otherwise result in such purchaser's beneficial ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%) of the Company's outstanding Class A common stock, if any such purchaser so chooses. Each pre-funded warrant is exercisable at any time to purchase one common share at an exercise price of $0.0001 per share. Gross proceeds from the offering, before deducting the placement agent's fees and other offering expenses, were approximately $6.0 million. The Company intends to use the proceeds of the offering for working capital, general corporate purposes, payments to a third-party marketing agency for services related to marketing and advertising, strategic investments, and any additional future acquisition (if any).
位于维吉尼亚比奇市的Inspire Veterinary Partners,Inc.(纳斯达克:IVP)(以下简称“Inspire”或“公司”)是一家在美国提供宠物医疗保健服务的所有者和提供者,今天宣布关闭其先前宣布的公开发行600万个单位的交易,每个单位包括公司A类普通股一股或预先担保认股权证一份和购买公司A类普通股一股的认股权证一份,公开发行价为每个单位1.00美元。如果购买者出于任何原因选择这种方式,预先担保的认股权证按比例发行给购买者,以代替购买者的受益所有权超过公司现有的A类普通股的4.99%(或在购买者选择时为9.99%)的情况。每个预先担保认股权证可随时行使,以按每股0.0001美元的行使价格购买一股普通股。除去配售代理的费用和其他发行费用之前,筹集到的总收益约为600万美元。公司计划将这些收益用于营运资金、普通企业目的、向第三方营销代理支付与营销和广告有关的服务、战略投资以及任何未来的额外收购(如有)。
Spartan Capital Securities LLC is acting as the sole placement agent in connection with the offering.
Spartan Capital Securities LLC是与本次发行相关的唯一配售代理。
The offering was conducted pursuant to the Company's registration statement on Form S-1, as amended (Reg No. 333-280194), initially filed with the Securities and Exchange Commission (the "SEC") on June 14, 2024, and subsequently declared effective by the SEC on July 2, 2024. The offering was made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained on the SEC's website located at http://www.sec.gov or from Spartan Capital Securities LLC at 725 Fifth Avenue, 23rd Floor, New York, NY 10022, or at
本次发行是根据公司修订后的S-1表格注册声明(注册编号为333-280194)进行的,该声明最初于2024年6月14日向证券交易委员会(以下简称“SEC”)提交,并于2024年7月2日由SEC宣布生效。本次发行仅通过一份招股书进行。有关本次发行的招股书副本可从SEC网址http://www.sec.gov或位于纽约市第五大道725号23楼的Spartan Capital Securities LLC处获取。
This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.
此新闻稿不构成任何证券的销售要约或要约,也不在任何州或其他司法辖区进行出售是违法的,在任何此类州或其他司法辖区之前,该等证券的注册或符合注册条件或适用证券法在该等州或其他司法辖区的要求。
About Inspire Veterinary Partners, Inc.
关于Inspire Veterinary Partners,Inc。
Inspire Veterinary Partners is an owner/operator of veterinary hospitals in the US. As the Company expands, it expects to acquire additional veterinary hospitals, including general practice, mixed animal facilities, and critical and emergency care.
Inspire Veterinary Partners是美国兽医医院的所有者/运营商。随着公司的扩张,它预计将收购其他兽医医院,包括一般实践,混合动物设施和重要和紧急护理。
For more information, please visit: .
欲了解更多信息,请访问:
Connect with Inspire Veterinary Partners, Inc.
联系Inspire Veterinary Partners,Inc。
Facebook
Facebook
LinkedIn
Forward-Looking Statements
LinkedIn
前瞻性声明
This press release contains forward-looking statements regarding the Company's current expectations. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, risks and uncertainties related to the satisfaction of customary closing conditions related to anticipated acquisitions, or factors that result in changes to the Company's anticipated results of operations related to acquisitions. These and other risks and uncertainties are described more fully in the section captioned "Risk Factors" in the Company's Registration Statements on Form S-1 filed with the SEC. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.
本新闻稿包含关于公司当前期望的前瞻性声明。这些声明并非对未来业绩的保证,而且有一定的风险、不确定性和难以预测的因素。可能导致实际结果不同的因素包括但不限于与预期收购相关的惯常结算条件的风险和不确定性,或导致公司预期的收购运营结果发生变化的因素。这些和其他的风险和不确定性在公司向SEC提交的S-1表格注册声明的“风险因素”一节中有更详细的描述。本公告中包含的前瞻性声明为本日期作出,并且除非适用法律要求,在此之后公司不承担更新此类信息的责任。
Investor Contact
投资者联系方式
TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com
TraDigital IR
Kevin McGrath
+1-646-418-7002
kevin@tradigitalir.com
General Inquiries
一般查询
Morgan Wood
Mwood@inspirevet.com
摩根伍德
Mwood@inspirevet.com
SOURCE: Inspire Veterinary Partners, Inc.
来源:Inspire Veterinary Partners, Inc.